US stocks surge | Eli Lilly (LLY.US) rises more than 8%; Q1 revenue increases by 56% year-on-year, raising full-year performance guidance.

According to the Wisdom Finance APP, on Thursday, Eli Lilly (LLY.US) rose more than 8%, closing at $925.30. In terms of news, in the first quarter of 2026, Eli Lilly's total revenue reached $19.8 billion, a year-on-year increase of 56%, significantly exceeding FactSet's expected $17.78 billion. Adjusted earnings per share were $8.55, a 156% increase from the same period last year's $3.34, also well above the market's expected $6.97. The company has raised its full-year revenue guidance to $82-85 billion, up from the previous forecast of $80-83 billion; full-year adjusted earnings per share guidance has been raised to $35.50-$37.00, from the previous $33.50-$35.00.